Skip to main content
Call for abstracts now open. Please consult the author guidance before submitting.
Medical AI topic

Healthcare AI Governance

Healthcare AI governance at ISMAI 2026 focuses on what hospitals, health systems and professional bodies must put in place before medical AI can be adopted responsibly. The topic includes institutional readiness, procurement, liability, monitoring, regulation, accountability and the ability to withdraw unsafe systems.

Official ISMAI 2026 event facts

Official
Event
International Symposium on Medical AI
Edition
ISMAI 2026
Dates
3-4 December 2026
Venue
Aula Magna CTO, AOU Careggi
City
Florence, Italy
Organiser
International Society of Medical AI
Format
In-person scientific symposium
How ISMAI 2026 covers this

How ISMAI 2026 approaches this theme

The Florence symposium treats governance as an operational discipline: it must work in real hospitals, under real regulatory conditions.

Sessions consider procurement, contractual obligations, monitoring arrangements and the clarity of liability across clinicians, institutions and suppliers.

Discussion covers the regulatory landscape and the practical mechanisms needed to withdraw or restrict a system that no longer performs safely.

Relevant programme session

This theme is developed in Session 5: The Governable AI Hospital of the ISMAI 2026 scientific programme. Sessions run under Chatham House rules where clinical case material is discussed, so that presentations remain candid without compromising confidentiality.

Relevant abstract tracks

Authors submitting original work related to this theme should consider the following tracks. Full track scopes and review criteria are published on the call for abstracts.

  • AI Governance and Regulation
  • Hospital Readiness and Organisational Transformation
  • Patient Safety and Risk Management
  • Validation, Monitoring and Model Lifecycle

Who this topic is for

  • Hospital and health-system leaders responsible for AI governance.
  • Clinical directors, procurement leads and quality and risk teams.
  • Regulators, legal advisers and policy staff engaged with medical AI.
Next steps

Continue from this topic

Read alongside the programme and the abstract call, or explore how the theme is treated for a specific audience.

Other medical AI topics

Last updated: 1 July 2026